RAKESH RANJAN: Open Payments
NPI 1073549606 · MEDINA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,399 in 172 payments from 14 companies in 2025. Trend: 2023 $44,331 · 2024 $38,395 · 2025 $12,399
Speaker / faculty: $8,508Food & beverage: $2,963Consulting: $705Education: $223
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 26 | $10,221 |
| Otsuka America Pharmaceutical, Inc. | 47 | $682 |
| Vanda Pharmaceuticals Inc. | 21 | $371 |
| Alkermes, Inc. | 11 | $229 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $220 |
| ABBVIE INC. | 12 | $196 |
| E.R. Squibb & Sons, L.L.C. | 17 | $153 |
| Indivior Inc. | 4 | $77 |
| Supernus Pharmaceuticals, Inc. | 3 | $60 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
Products named: AUSTEDO XR, REXULTI, HETLIOZ, ARISTADA, CAPLYTA, VRAYLAR, COBENFY, ABILIFY ASIMTUFII.
Industry payments across OH — which companies pay providers there.
